Platelet-activating factor (PAF) is a potent lipid mediator of allergic inflammation through its interaction with eosinophils. Expression of the PAF receptor is modulated by many agents, including those responsible for cell differentiation. We report here that differentiation of a human eosinophilic leukaemia cell line, EoL-1, by sodium n-butyrate is associated with induction of PAF receptor gene expression, as In the present study, using a human eosinophilic leukaemia cell line, EoL-1 [9], we describe the regulation, structure and signal transduction of PAF receptor during eosinophilic differentiation.
INTRODUCTION
Platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF) is a potent proinflammatory mediator, which causes microvascular leakage, vasodilatation, contraction of smooth muscle, and activation of neutrophils, macrophages and eosinophils [1] [2] [3] [4] . The accumulation ofeosinophils in affected tissues characterizes many allergic disorders, including bronchial asthma and atopic dermatitis. Eosinophil chemotactic factors such as PAF, a complement fragment C5a, and formyl-methionyl-leucyl-phenylalanine (fMLP) not only induce chemotaxis [5] but also enhance many functions of eosinophils. PAF releases eosinophil peroxidase and other granular contents from human eosinophils [6, 7] . Although specific binding of [3H]WEB 2086 to PAF receptor was identified in eosinophils [8] , no direct data are available concerning the structure and the regulation of PAF receptor at the molecular level. Thus, mechanisms related to the induction of PAF receptor and the responses of eosinophils to PAF are important when considering the roles of eosinophils in allergic disorders.
In the present study, using a human eosinophilic leukaemia cell line, EoL-1 [9] , we describe the regulation, structure and signal transduction of PAF receptor during eosinophilic differentiation. 
MATERIALS AND METHODS

Cells
EoL-l cells were a kind gift from Drs. H. Saito (Yamagata Prefectural Central Hospital, Yamagata, Japan) and H. Saito (National Sagamihara Hospital, Kanagawa, Japan). EoL-1 cells were maintained in suspension culture at 37°C and 5 % CO2 in humidified atmosphere in RPMI-1640 medium supplemented with 10 % (v/v) heat-inactivated fetal calf serum, 0.03 % (w/v) Lglutamine, 100 i.u./ml penicillin and 100 ,sg/ml streptomycin. For differentiation, EoL-1 cells were diluted to 5 x 105cells/ml and 0.5 mM sodium n-butyrate was added. When EoL-1 cells were incubated with 0.5 mM sodium n-butyrate for 5 days, the percentage of cells responding to Luxol Fast Blue staining increased from 1.8+0.4 to 9.4+2.6% (mean+S.D., n = 5).
In some experiments, PTX (0.1-100 ng/ml) or its vehicle was added to the culture medium and the cells were incubated for an additional 24 h. Under the current conditions, when EoL-1 cells were treated with PTX (100 ng/ml) for 24 Assays for leukotriene (LT)A4 hydrolase and LTC4 synthase Eosinophils have been reported to produce LTC4 preferentially to LTB4 [10] . Two enzyme activities (LTA4 hydrolase and LTC4 synthase) of cell homogenates were assayed as described previously [11] , to study the ability of EoL-l cells to produce LTs. Cells at a different stage of differentiation were seeded (1 x 107 cells/ml) in Tyrode's buffer and sonicated for 3 s at 60 W using a Model 5202 sonicator (Ohtake Works, Tokyo). The cell homogenates were centrifuged at 10000 g for 10 min at 4 'C. The resulting supernatant was incubated with 70,uM LTA4 and 5 mM glutathione for 5 min. The amount of LTC4 and LTB4 in the products was analysed by a reversed-phase h.p.l.c. The activity was expressed as m-units/106 cells, where one unit was defined as the activity required to produce one ,umol of product/ 5 min.
Construction and screening of an ZAP 11 cDNA library RNA was prepared from EoL-1 cells treated with 0.5 mM sodium n-butyrate for 3 days by the acid guanidium thiocyanate/phenol/chloroform method [12] . The cDNA synthesis was carried out with oligo(dT)-primed poly(A)+ RNA, using a cDNA Synthesis Kit (Pharmacia). The cDNA was inserted into the EcoRI site of AZAP II vector (Stratagene). Clones (3 x 105) were first screened by hybridization with the PstI-EcoRV fragment (-1.2 kbp, including the full coding region) of the human PAF receptor cDNA [13] . Hybridization was carried out in solution containing 6 x SCC (0.15 M NaCl, 0.015 M sodium citrate), S x Denhardt's solution [0.1 % (v/v) BSA, 0.1 % (v/v) poly(vinylpyrrolidone), 0.1 % (v/v) Ficoll 400], 0.5 % (w/v) SDS, 400 ,ug/ml heat-denatured salmon sperm DNA, and the radiolabelled probe (2 x 106 c.p.m./ml) at 55 'C for 18 h. Filters were washed with 2 x SCC, 0.1 % SDS at 55 'C for 20 min and then with 0.5 x SCC, 0.1 % SDS at 55 'C for 15 min. After tertiary screening, six independent clones were isolated. These phages containing the cDNA inserts were converted to plasmids by rescue excision, according to the manufacturer's instructions. The restriction mapping of the inserted cDNAs was examined. DNA sequencing was performed by the method of Sanger et al. [14] with [a-32P]dATP and T7 DNA polymerase (Pharmacia) on both strands, using synthetic oligonucleotides as sequencing primers.
Northern blot analysis
Poly(A)+ RNAs obtained from different stages of EoL-I cells were resolved on a 0.7 % (w/v) agarose gel containing 6.7 % (v/v) formaldehyde and blotted onto a Hybond-N+ nylon membrane (Amersham). The blot was hybridized with the 32p_ labelled PstI-EcoRV fragment of human PAF receptor cDNA at 65 'C for 18 h. The membrane was successively washed at 65 'C in 2 x SCC, 0.1 % SDS for 20 min and then in 1 x SSC for 20 min before being exposed for 7 days to a X-ray film at -70 'C with an intensifying screen. The membrane was washed in 95 'C distilled water for 30 min and was then rehybridized with the 32p_ labelled human fl-actin probe (Funakoshi, Tokyo). After being washed as described above, the membrane was exposed to a Xray film for 20 h. [3H]WEB 2086 binding assay
The ligand binding was assayed as described previously [13] . The membrane fractions of EoL-l cells were incubated with 20 nM Photo Film Co., Tokyo) was used to quantify hybridized signals.
[3H]WEB 2086 (a PAF antagonist) [16] at 25°C for 60 min in the presence (for the non-specific binding) or absence (for the total binding) of 10 gM WEB 2086, and the radioactivity on a Whatman GF/C glass-fibre filter was measured. For the displacement study, the binding with 10 nM [3H]WEB 2086 was inhibited by various concentrations (10-12-10-6 M) of PAF, Y24180, CV 6209, or WEB 2086, and IC50 values for each drug were determined by three independent experiments.
Determination of cytosolic free Ca2+ and Inositol trisphosphates
Changes in intracellular free Ca2+ concentration ([Ca2+]i) induced by PAF were measured by fluorimetry, as described previously [17] . EoL-1 cells (3 x 105 cells) loaded with 3 ,M Fura 2-AM were incubated at 37°C with 1 mM CaCl2 for 10 min, and PAF solutions were added.
The production ofmyo-D-inositol 1,4,5-trisphosphate (IP3) was measured as described previously [18] with some modifications. 
RESULTS
Effects of sodium n-butyrate on cell differentiation
The increasing percentage of the Luxol Fast Blue positive cells (from 1.8 to 9.40% after culturing for 5 days with sodium nbutyrate) indicated that this treatment committed EoL-l cells to the eosinophilic lineage, as Luxol Fast Blue staining is a specific method for the detection of eosinophilic granules. But the proportion of the eosinophilic-granule-positive cells was not as large, probably because the granules of the differentiated EoL-1 cells were immature compared with those of normal eosinophils. It was reported that the granules of the differentiated EoL-l cells lacked the crystalloid core and matrix usually observed in mature eosinophil granules [9] . The enzyme activities of LTA4 hydrolase and LTC4 synthase increased time-dependently, and reached approx. 3-and 8-fold higher values after culturing for 7 days respectively (Figure la) . The LTC4 synthase activity was much higher than the LTA4 hydrolase activity. This predominant production of LTC4was thought to be characteristic of eosinophils [10] . Thus, EoL-1 cells revealed the eosinophilic phenotype when treated with sodium n-butyrate. inhibited by PAF (IC50 1.3 nM), followed by Y24180 ( (Figure lc) . . 
Induction of PAF receptor mRNA during differentiation
The expression of the human PAF receptor gene in undifferentiated and differentiated EoL-1 cells was investigated. Poly(A)+ RNAs isolated from these cells were hybridized with the human PAF receptor cDNA. Two bands were detected, a major band of size 3.8 kbp and a minor band of size 4.2 kbp, whose intensity was about one sixth of the major band, as determined by a FUJIX BAS-2000 bioimage analyser (Figure 2a) . The size of the major band was the same as that reported previously in human leukocytes and EoL-1 cells [13] , and the 4.2 kbp band may represent a minor species of PAF receptor mRNA (discussed below). Undifferentiated cells expressed a relatively low level of PAF receptor mRNA. After a 1 h exposure to butyrate, the mRNA level was slightly increased, and at 6 h the signal doubled. After a 3 day exposure, the amount of PAF receptor mRNA increased 3.5-fold and reached a plateau (Figure 2b ). These data indicate that the increase of PAF receptor during cell differentiation is regulated at the transcriptional level. Cloning and sequencing of the PAF receptor cDNA The molecular heterogeneity of PAF receptor has been suggested in many cells and tissues [19] [20] [21] , including eosinophils [22] . To investigate whether EoL-cells have the same type of receptor as leukocytes, we cloned the PAF receptor from a cDNA library of day-3 differentiated EoL-1 cells. Six independent clones (EP-1 to -6) were isolated. These clones were sequenced on both strands, and they have nucleotide sequences identical with that of the human leukocyte cDNA (Figure 3) . Thus, the PAF receptor protein of EoL-1 cells is the same as that of leukocytes, except possibly for post-translational modifications. We reported previously two types of mRNA (Transcript 1 and 2) for the human PAF receptor, the difference being divergent 5-non-coding sequences [23, 24] . Human leukocytes and EoL-l cells have only Transcript 1, whereas other cells and tissues possess both Transcript 1 and Transcript 2 [24] . All isolated clones from the EoL-1 cDNA library had nucleotide sequences corresponding to that of Transcript 1. These data indicate that the expression of PAF receptor gene in EoL-I cell is regulated by the same promoters as in leukocytes.
The 5' ends of the five isolated clones were located downstream of the putative transcription start sites identified by our previous study [24] , but EP-6 had a longer 5-non-coding region. encoded some of the identical sequence to a genomic clone 'exon 1' and it contained the major transcriptional start site (TCCTCTTTCTCAC) which included a highly homologous sequence to the 'initiator' (CCTCATTCT) found in the murine terminal deoxynucleotidyltransferase gene. As the 'initiator' is reported to represent the functional promoter related to cellular differentiation and development [25, 26] , this start site may play an important role in the induction of PAF receptor during differentiation of EoL-l cells. Considering the structure of EP-6 and the 4. 
FACScan analysis of PAF receptor protein
We developed monoclonal antibodies against a synthetic peptide, corresponding to the guinea pig PAF receptor residues 158-173 in the second extracellular loop of the putative tertiary structure. Ab-IV recognized the guinea pig PAF receptor expressed in CHO cells (Figure 4a ). Figure 4 (b), significant labelling of hPAF-2 cells was observed. Two human lymphocyte cell lines were subjected to FACScan analysis. A B-cell line, Raji, reported to possess PAF receptor [27] , was strongly labelled, but a T-cell line MOLT 4 was labelled at a low level (Figure 4c ). One previous report demonstrated that T lymphocytes do not express PAF receptor without proper activation [28] , whereas another report suggested that PAF represents a potential cellular mediator in MOLT 4 [29] . Partial activation could be the reason for the low level of surface labelling detected in MOLT 4 cells.
Although undifferentiated EoL-1 cells transcribed only very low levels of PAF receptor mRNA (Figure 2 ), they expressed some receptor protein at their cell surface (Figure 4d ). During the differentiation with sodium n-butyrate, day-I EoL-1 cells were labelled more strongly than undifferentiated cells and day-3 cells were highly labelled.
Effects of PTX on Ca2+ mobilization and IP3 production PAF induced intracellular Ca2+ mobilization in EoL-l cells. The type of G-protein(s) involved in the PAF responses may differ from cell to cell [30, 31] . In CHO cells expressing the guinea pig PAF receptor, PTX is not inhibitory to PAF-induced IP3 production [18] . To investigate the roles of G, protein in PAFreceptor-induced intracellular signal transduction, day-7 differentiated EoL-l cells were treated with PTX. The increases in
[Ca2+], were inhibited dose-dependently (results not shown). When cells were incubated with 100 ng/ml of PTX (all G, was ADP-ribosylated at this concentration), the increase of [Ca2+1] was inhibited by 50% (Figure 5a ). [34] . In EoL-1 cells, the amount of mRNA for the PAF receptor increased with the combination of interleukin-5, granulocyte/ macrophage colony-stimulating factor, and n-butyrate [13] , and Ca2+ mobilization with PAF was induced by dibutyryl cyclic AMP [35] . However, no direct evidence has been obtained on the structure and regulation of PAF receptor at the molecular level.
In the present work, we demonstrate for the first time that gene expression and function of the PAF receptor are coupled to the cellular differentiation of EoL-l cells by sodium n-butyrate. Though various tissues and cells contain two species of mRNA for PAF receptor [24] , EoL-1 cells have only one kind of mRNA as leukocytes. So, the gene expression is controlled by the promoter regions of 'exon 1', which contains transcription factors such as NF-KB and Sp-1, and the putative initiator highly homologous to the 'initiator' found in the murine terminal deoxynucleotidyltransferase gene. This 'initiator' might also act as the functional promoter related to the cellular differentiation and to development in EoL-l cells. Northern blot analysis and the isolation of the longer-sized clone, EP-6, indicate the existence of a minor transcription start site.
When PAF binds to its receptor, it activates G-protein, which in turn can activate either a phosphoinositide-specific PLC or can inhibit adenylate cyclase. The G-protein(s), PLC and/or adenylate cyclase constitute the 'signal-transducer proteins' for PAF receptor in various cells and tissues [31, 36] . The type of Gprotein(s) involved in the PAF responses may differ from cell to cell, and depend on which effector system is coupled [30, 31] . PAF-stimulated IP3 production was sensitive to PTX treatment in rabbit neutrophils, human macrophages, and human platelets, and partially sensitive in A431 cells and rabbit platelets. However, it was resistant in U937 cells and peripheral blood mononuclear leukocytes (reviewed in [31] ). Thus, both PTX-sensitive and -insensitive G-protein may be involved in the PLC pathway through PAF receptor. In a previous study, PTX attenuated PAF-induced [Ca2+]1 changes in human eosinophils [37] . Our present results also suggest that the PLC pathway is largely coupled with PTX-sensitive G-protein(s) in EoL-l cells. This PLC pathway through the PAF receptor is involved in Ca2+-dependent cellular responses, such as degranulation in eosinophils [22, 37] .
We have characterized the expression of specific, biologically active receptors for PAF as a newly recognized function of eosinophilic differentiation in EoL-l cells. This provides a well characterized system useful for studies of mechanisms of PAFstimulated cellular signal-transduction events and for identifying regulatory factors for leukocyte-type mRNA to express PAF receptors.
